Skip to main content
. 2018 Aug;59(8):1219–1224. doi: 10.2967/jnumed.117.203299

FIGURE 2.

FIGURE 2.

(A) SUVave time–activity curves for 89Zr-labeled IgG and 89Zr-anti-CD20 antibodies from PET. (B) Tumor SUVave and tumor SUVmax time–activity curves of 89Zr-labeled antibodies. Obi = obinutuzumab; Ofa = ofatumumab; Rtx = rituximab; Tos = tositumomab. Data are mean ± SEM.